Five years ago, nobody outside the Alps was reaching for génépy. Now it's turning up as a backbar staple, standing in for Chartreuse in everything from White Negronis to Whiskey Sours, according to Punch. No allocation drama, no bartender hoarding bottles under the bar, no brand mythology about monks and secret recipes. Just a liqueur that got good distribution, got into the right hands, and did the job.
That's the tell. Génépy is made by steeping the artemisia plant in neutral alcohol, and it's genuinely a close cousin to Chartreuse in profile — herbal, alpine, built for the same cocktail slots — but it arrived in the American bar world without the artificial drama that's turned Chartreuse into a trophy ingredient. Nikki Irvine uses it in the Petrichor to bottle the smell of rain; Toby Maloney built the Swiss Kiss around it and described the result as "cool and sophisticated as a Swiss diplomat at a party of spies," per Punch. At San Francisco's ABV, Ryan Fitzgerald paired it with Hakushu in the High Altitude Highball on the logic that both ingredients come from mountain terrain and carry that influence, the same source notes. None of that required anyone to frame génépy as rare. It just had to be good.
Compare that to the Chartreuse conversation, which I've hammered on before: a liqueur whose actual production constraints get laundered into a marketing asset, so scarcity reads as prestige instead of a supply problem. Génépy proves you don't need the mystique to build a following — you need bartenders who'll actually put the bottle in a drink and talk about what it does. Troy Sidle uses it to sweeten cream for a coffee cocktail; Ryan Maybee folds it into a Génépy Suisse alongside crème de cacao and absinthe for what amounts to an elevated mocha, both per Punch. That's drink-first thinking, not bottle-first thinking.
It also tracks with a broader shift happening in home-bar writing right now — Imbibe's own seasonal roundups keep leaning on underused modifiers like Cynar and absinthe to do real flavor work rather than garnish duty, per Imbibe. The ingredients getting attention this fall aren't the scarce ones. They're the useful ones.
If génépy keeps climbing, watch whether American producers start bottling domestic versions at scale, which Punch flags as already underway. That's the real test: whether it stays a working ingredient once it's no longer novel, or whether the hype catches up and ruins it the way hype ruins everything else.